Riluzole Regulates Pancreatic Cancer Cell Metabolism by Suppressing the Wnt-β-Catenin Pathway

The authors reported that riluzole inhibited pancreatic cancer cell growth and had no effect on human pancreatic normal ductal epithelial cells.